Oragenics, Inc. (OGEN) financial statements and ratios from SEC XBRL: revenue $182229.00 (TTM), net margin -5401.2%, revenue growth 297.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $182229.00 |
| Net Margin | -5401.2% |
| Revenue Growth (YoY) | 297.0% |
| EPS Growth (YoY) | 185.0% |
| Price / Book | 0.64 |
| Price / Sales | 13.06 |
| Sector P/E (Healthcare) | 21.7 |
OGEN overview · OGEN earnings · OGEN KPIs · OGEN investor relations · OGEN ownership · OGEN peers · OGEN filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.